インスリンポンプの世界市場2016-2020

◆英語タイトル:Global Insulin Pumps Market 2016-2020
◆商品コード:IRTNTR9553
◆発行会社(調査会社):Technavio
◆発行日:2016年6月7日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、インスリンポンプの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、インスリンポンプの世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Insulin Pumps Market
Diabetes is a common metabolic disease in which an individual’s blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes, the body does not produce sufficient insulin, and it is usually diagnosed in children and young adults. The most common type of diseases is type 2. In this type, the body is incapable of utilizing insulin.
Insulin pump therapy is the most preferred alternative delivery method of administrating insulin instead of insulin pens and needles. It is able to reduce the rate of recurrence of severe hypoglycemia and is capable of improving the quality of life for insulin pump users.
An insulin pump is a small-sized high-tech electronic device that can be connected to the body via an infusion set to deliver small doses of rapid-acting insulin to meet the basal needs. This device offers flexibility to people with type 1 diabetes.

Technavio’s analysts forecast the global insulin pumps market to grow at a CAGR of 8.05% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global insulin pumps market for 2016-2020. To calculate the market size, we consider revenue generated from the sale of insulin pumps.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Insulin Pumps Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Animas
• Insulet
• Medtronic
• Roche Diagnostics

[Other prominent vendors]
• Bayer
• GlySens
• IA Collaborative
• MicroPort
• Senseonics
Tandem
• Valeritas

[Market driver]
• Focus on diabetes management
• For a full, detailed list, view our report

[Market challenge]
• Inadequate reimbursements
• For a full, detailed list, view our report

[Market trend]
• Adoption of insulin pumps over conventional methods
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Research methodology

PART 03: Market research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Background

PART 05: Insulin pumps: An overview
• Complications of diabetes
• Incidence and prevalence
• Insulin pump therapy

PART 06: Cost analysis

PART 07: Market landscape
• Market overview
• Market size and forecast

PART 08: Five forces analysis

PART 09: Leading country: Insulin pumps market in the US
• Market size and forecast

PART 10: Market segmentation by product type

PART 11: Geographical segmentation
• Insulin pumps market in Americas
• Insulin pumps market in EMEA
• Insulin pumps market in APAC

PART 12: Market drivers
• Increased prevalence of diabetes
• Increase in older adult population
• Focus on diabetes management
• Rise in public awareness

PART 13: Impact of drivers
• High cost

PART 14: Market challenges
• Availability of alternatives
• Inadequate reimbursements
• Intense competition among vendors

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Advances in insulin pumps
• Adoption of insulin pumps over conventional methods
• Competitive scenario

PART 17: Vendor landscape
• Market share analysis 2015
• Animas

PART 18: Key vendor profiles
• Insulet
• Medtronic
• Roche Diagnostics
• Other prominent vendors

PART 19: Appendix
• List of abbreviation

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: IDF estimate of diabetes population by region 2015
Exhibit 03: Cost breakdown of insulin pump therapy 2014
Exhibit 04: Cost breakdown of MDI 2014
Exhibit 05: Cost analysis of insulin pump consumables 2014
Exhibit 06: Cost analysis of MDI consumables for fast acting vial 2014
Exhibit 07: Cost analysis of MDI consumables for basal/long-acting insulin 2014
Exhibit 08: Cost comparison of MDI 2014
Exhibit 09: Average cost of cartridges offered by some of leading vendors 2014
Exhibit 10: Global insulin pumps market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Insulin pumps market in the US 2015-2020 ($ millions)
Exhibit 13: Global insulin pumps market by geography 2015
Exhibit 14: Insulin pumps market in Americas 2015-2020 ($ millions)
Exhibit 15: Insulin pumps market in EMEA 2015-2020 ($ millions)
Exhibit 16: Insulin pumps market in APAC 2015-2020 ($ millions)
Exhibit 17: Global insulin pumps market by geography 2015-2020 ($ millions)
Exhibit 18: Global insulin pumps market by geography 2015-2020
Exhibit 19: Estimated percentage of older adult population 2012 and 2050
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Vendor ranking of global insulin pumps market 2015
Exhibit 23: Global insulin pumps market share analysis 2015
Exhibit 24: Product matrix
Exhibit 25: Animas: Key takeaways
Exhibit 26: Insulet: Key takeaways
Exhibit 27:
Exhibit 28: Diabetes group by revenue 2013-2015 ($ billions)
Exhibit 29: Medtronic: Key takeaways
Exhibit 30: Diabetic care 2013-2015 ($ billions)
Exhibit 31: Roche Diagnostics: Key takeaways



【掲載企業】

Animas, Insulet, Medtronic, Roche Diagnostics, Bayer, GlySens, IA Collaborative, MicroPort, Senseonics, Tandem, Valeritas.

【レポートのキーワード】

インスリンポンプ療法、糖尿病、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[インスリンポンプの世界市場2016-2020]販売に関する免責事項
★調査レポート[インスリンポンプの世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆